Rifoldin Dragees

Recall | Medicines | 10/02/2015

The marketing authorization holder informed its supplied customers in a letter dated February 9, 2015, that the specified batches were being recalled because deviations from the specified dissolution value had been detected in the samples returned.

Name of the medicinal product Rifoldin 600 mg Dragees
Marketing authorisation number(s) 15.693
Marketing authorisation holder sanofi-aventisGmbH, 1220 Wien
Batch number(s) 3J298A, 3D253A, 2L195A, 2E172A
Classification of the recall2
BASG reference number INS-640.001-1335

Further inquiry note